According to a study, 2/3rd of Indian Adults are unaware of Adult Vaccination Rainbow Children’s Hospital, one of the pioneers of Pediatric care in India launched AVON – Adult Vaccination Outreach Network with a mission to vaccinate the adult population in the country. Being a leader
According to a study, 2/3rd of Indian Adults are unaware of Adult Vaccination Hyderabad, 29th July, 2024: Rainbow Children’s Hospital, one of the pioneers of Pediatric care in India launched AVON – Adult Vaccination Outreach Network with a mission to vaccinate the adult population in the
The U.S. Centers for Disease Control and Prevention has recommended that individuals aged six months and older should be given an updated COVID-19 vaccine for the 2024-25 immunization campaign, irrespective of whether they have previously been vaccinated for the disease. The agency's recommendation on Thursday echoed
The appointment is effective as of May 16, 2024. In her new role, Annapurna will lead the Company in India, ensuring patient access to its highly innovative medicines and vaccines, and advancing valuable collaborations to contribute to the growing domestic healthcare and pharmaceutical market. (TSE:4502/NYSE:TAK) Takeda Biopharmaceuticals
Abrocitinib is the first-of-its-kind oral advanced systemic treatment for adults with moderate-to-severe atopic dermatitis, to be made available in India. Abrocitinib provides rapid itch relief, sustained control of the disease and improved quality of life. Pfizer has received marketing authorization for abrocitinib in adults
Health and Wellness NCD screening kiosks set up in 4 hospitals Virtual Patient Helpdesk engages with over 50,000 patients Over 5000 General Practitioners and ASHA workers trained in early detection and palliative care services Patient tracking and referral app launched Pfizer today announced that its
Avifavir® is effective against various variants of coronavirus, including Delta and Omicron, as it affects the highly conservative and mutation-resistant replication systems of RNA virus (RdRp). The virus is incapable of developing resistance to favipiravir even with long-term exposure on infected cells, as has been confirmed
On Monday, Moderna Inc (MRNA.O) said its COVID-19 vaccine which generated a strong immune response in children aged six to 11 years and that it plans to submit the data to global regulators soon. Moderna said its two-dose vaccine generated virus-neutralizing antibodies in children and
Vaccines for kids between the ages of 5 and 11 will likely be available in the first half of November, top U.S. infectious disease expert Anthony Fauci said on Sunday, predicting a timetable that could see many kids getting fully vaccinated before the end of
On Thursday, the U.S. Centers for Disease Control and Prevention (CDC) recommended the COVID-19 vaccine boosters for recipients of the Moderna Inc (MRNA.O) and Johnson & Johnson (JNJ.N) shots, and said Americans can choose a different shot from their original inoculation as a booster. CDC director
